Pharmacokinetics and Pharmacodynamics Practice Questions

Q: What causes the rapid awakening from a single bolus dose of Propofol?

Redistribution. **Explanation:** The rapid recovery from a single bolus dose of Propofol is due to **Redistribution**, not metabolism or excretion. **1. Why Redistribution is Correct:** Propofol is a highly lipid-soluble drug. Upon intravenous administration, it rapidly reaches organs with high blood flow (the **vessel-rich group**), primarily the brain, leading to a quick induction of anesthesia. However, as plasma levels fall, the drug quickly moves out of the brain and "redistributes" into less vascular but high-capacity tissues like skeletal muscle and adipose tissue. Since the concentration in the brain drops below the therapeutic threshold, the patient awakens within 5–10 minutes, even though the drug is still present in the body. **2. Why Other Options are Incorrect:** * **Excretion:** Renal or biliary clearance is too slow to account for the immediate awakening (minutes) seen with Propofol. * **Biotransformation (Metabolism):** While Propofol is rapidly metabolized by the liver (glucuronidation), the rate of metabolism does not match the speed of recovery from a single bolus. Metabolism determines the *elimination* half-life, whereas redistribution determines the *distribution* half-life ($\alpha$-half-life). * **D-Methylation:** This is not a primary metabolic pathway for Propofol. **High-Yield Clinical Pearls for NEET-PG:** * **Context-Sensitive Half-Time:** While recovery from a *bolus* is due to redistribution, recovery from a *prolonged infusion* depends on metabolism, as peripheral tissues become saturated. * **Propofol Infusion Syndrome (PRIS):** A rare, fatal complication of long-term high-dose infusion characterized by metabolic acidosis, rhabdomyolysis, and cardiac failure. * **Drug of Choice:** Propofol is the preferred agent for Day Care Surgery due to its rapid recovery and anti-emetic properties.

Q: A drug administered through which of the following routes undergoes high first-pass metabolism?

Oral. **Explanation:** **1. Why Oral is Correct:** The oral route is the most common route associated with high **first-pass metabolism** (presystemic metabolism). When a drug is swallowed, it is absorbed from the gastrointestinal tract into the **portal venous system**. Before reaching the systemic circulation, the drug must pass through the **liver**, which is the primary site for drug metabolism. If the liver enzymes (like Cytochrome P450) metabolize a significant fraction of the drug during this initial passage, its bioavailability is drastically reduced. **2. Why Incorrect Options are Wrong:** * **Sublingual:** Drugs absorbed through the buccal mucosa drain directly into the superior vena cava, bypassing the portal circulation and the liver. This ensures rapid action and higher bioavailability (e.g., Nitroglycerin). * **Intravenous (I.V.):** This route bypasses all absorption barriers and the liver initially, delivering 100% of the drug directly into the systemic circulation. * **Intramuscular (I.M.):** The drug is absorbed from the muscle capillaries into the systemic venous return, bypassing the portal system and avoiding first-pass metabolism. **3. High-Yield Clinical Pearls for NEET-PG:** * **Definition:** First-pass metabolism occurs in the gut wall, portal vein, and most significantly, the **liver**. * **Drugs with high first-pass metabolism:** Nitroglycerin (hence given sublingually), Propranolol, Lidocaine, Morphine, and Salbutamol. * **Rectal Route:** Only the upper part of the rectum drains into the portal system; the lower part drains into the systemic veins. Therefore, the rectal route **partially** bypasses first-pass metabolism (~50%). * **Bioavailability (F):** High first-pass metabolism leads to low bioavailability. It is calculated as: $F = \text{Fraction absorbed} \times (1 - \text{Extraction ratio})$.

Q: Which of the following statements regarding transfer of drugs across the placenta is FALSE?

Ion trapping of acidic drugs occurs in the placenta.. **Explanation:** The transfer of drugs across the placenta is governed by lipid solubility, molecular weight, and the pH gradient between maternal and fetal blood. **1. Why Option C is the Correct (False) Statement:** The fetal blood is slightly more **acidic** (pH ~7.3) than maternal blood (pH ~7.4). According to the pH partition hypothesis, **basic drugs** (like local anesthetics or opioids) cross the placenta in an uncharged state and become ionized in the relatively acidic fetal environment. Once ionized, they cannot diffuse back into the maternal circulation, leading to accumulation. This is known as **ion trapping of basic drugs**, not acidic drugs. Acidic drugs remain largely unionized in the maternal blood and do not "trap" in the fetus. **2. Analysis of Other Options:** * **Option A:** In early pregnancy, the placental membrane is thicker and the surface area is smaller. As pregnancy progresses, the membrane thins and surface area increases, making drug transfer **greater in late pregnancy** and lesser in early pregnancy. * **Option B:** Most drugs cross the placenta via simple diffusion. Large molecular weight substances like **Heparin** (high MW) and **Insulin** (large peptide) are notable exceptions that do not cross the placental barrier. * **Option D:** The placenta contains efflux transporters like **P-glycoprotein (P-gp)** and BCRP. These act as a protective mechanism by pumping certain xenobiotics and drugs back into the maternal circulation. **High-Yield Clinical Pearls for NEET-PG:** * **Rule of Thumb:** Drugs with MW ** 1000 Daltons** (like Heparin) do not. * **Warfarin vs. Heparin:** Warfarin is teratogenic (crosses placenta); Heparin is the anticoagulant of choice in pregnancy (does not cross). * **Local Anesthetics:** During labor, lidocaine (a weak base) can undergo ion trapping in the fetus, potentially leading to neonatal depression.

Q: A 57-year-old man receiving mechanical ventilation contracts pneumonia caused by Pseudomonas aeruginosa. The patient is given antibiotic therapy with ceftazidime and gentamicin. Assuming the half-life of gentamicin is 3 hours in this patient, what percentage of the initial dose will most likely remain in his body 6 hours later?

25%. ### Explanation **1. Why the Correct Answer is Right:** The question tests the fundamental concept of **Half-life ($t_{1/2}$)**, which is the time required for the plasma concentration of a drug to decrease by 50%. * **Initial Dose:** 100% * **After 1 Half-life (3 hours):** The concentration drops by half. (100% $\div$ 2 = **50%**) * **After 2 Half-lives (6 hours):** The concentration drops by half again. (50% $\div$ 2 = **25%**) Since the patient’s $t_{1/2}$ is 3 hours, a 6-hour interval represents exactly **two half-lives**. Therefore, 25% of the initial dose remains in the body. **2. Why the Incorrect Options are Wrong:** * **Option A (12.5%):** This represents the amount remaining after **three** half-lives (3 $\times$ 3 = 9 hours). * **Option C (33%):** This is a distractor; drug elimination follows exponential (first-order) decay, not a simple linear division into thirds. * **Option D (50%):** This represents the amount remaining after only **one** half-life (3 hours). **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **First-Order Kinetics:** Most drugs (including Gentamicin) follow first-order kinetics, where a **constant fraction** of the drug is eliminated per unit time. * **Steady State:** It takes approximately **4 to 5 half-lives** for a drug to reach steady-state concentration or to be completely eliminated from the body. * **Gentamicin Dosing:** Gentamicin is an aminoglycoside excreted renally. In clinical practice, if a patient has renal impairment, the $t_{1/2}$ increases significantly, requiring dosage adjustment to prevent nephrotoxicity and ototoxicity. * **Synergy:** The combination of a Cell Wall Inhibitor (Ceftazidime) and a Protein Synthesis Inhibitor (Gentamicin) provides **synergistic bactericidal action** against *Pseudomonas*.

Q: Fexofenadine is a metabolic product of which drug?

Terfenadine. **Explanation:** **Correct Answer: D. Terfenadine** **Mechanism and Concept:** Fexofenadine is the active acid metabolite of **Terfenadine**, a second-generation H1-antihistamine. Terfenadine was originally developed as a non-sedating antihistamine; however, it was found to be a "prodrug" that undergoes extensive first-pass metabolism in the liver via the **CYP3A4** enzyme to form Fexofenadine. The clinical significance lies in safety: Terfenadine itself is cardiotoxic. It blocks delayed rectifier potassium channels ($I_{Kr}$) in the heart, leading to **QT interval prolongation** and the potentially fatal arrhythmia, **Torsades de Pointes**. This occurs especially when its metabolism is inhibited (e.g., by erythromycin or ketoconazole). Fexofenadine, however, provides the same antihistaminic benefits without the cardiotoxic effects, leading to the withdrawal of Terfenadine from most markets. **Analysis of Incorrect Options:** * **A. Loratadine:** It is a prodrug, but its active metabolite is **Desloratadine**. * **B. Astemizole:** Like Terfenadine, it was withdrawn due to QT prolongation. Its active metabolite is **Desmethylastemizole**. * **C. Cetirizine:** It is actually the active metabolite of **Hydroxyzine** (a first-generation antihistamine). **High-Yield NEET-PG Pearls:** * **Active Metabolites:** Remember the pairs: Terfenadine $\rightarrow$ Fexofenadine; Loratadine $\rightarrow$ Desloratadine; Hydroxyzine $\rightarrow$ Cetirizine. * **Cardiotoxicity:** Terfenadine and Astemizole are the classic examples of drugs causing Torsades de Pointes via CYP3A4 interactions. * **P-glycoprotein:** Fexofenadine is a substrate for P-glycoprotein, which limits its entry into the CNS, contributing to its highly non-sedating nature.

Question 1

What causes the rapid awakening from a single bolus dose of Propofol?

Accepted Answer

Redistribution

Answer

Excretion

Answer

Biotransformation

Answer

D-Methylation

Question 2

A drug administered through which of the following routes undergoes high first-pass metabolism?

Accepted Answer

Oral

Answer

Sublingual

Answer

Intravenous (I.V.)

Answer

Intramuscular (I.M.)

Question 3

Which of the following statements regarding transfer of drugs across the placenta is FALSE?

Accepted Answer

Ion trapping of acidic drugs occurs in the placenta.

Answer

Transfer across the placenta is lesser in early pregnancy.

Answer

All drugs to some extent can cross the placenta except heparin and insulin.

Answer

P–glycoprotein is present in the placenta.

Question 4

Which of the following statements is true about first-order kinetics?

Accepted Answer

The rate of elimination increases with an increase in drug concentration and decreases with a decrease in drug concentration.

Answer

Very few drugs follow first-order kinetics.

Answer

The half-life (t1/2) is constant.

Answer

Salicylates follow first-order kinetics throughout their therapeutic ranges.

Question 5

A 57-year-old man receiving mechanical ventilation contracts pneumonia caused by Pseudomonas aeruginosa. The patient is given antibiotic therapy with ceftazidime and gentamicin. Assuming the half-life of gentamicin is 3 hours in this patient, what percentage of the initial dose will most likely remain in his body 6 hours later?

Accepted Answer

25%

Answer

12.5%

Answer

33%

Answer

50%

Question 6

Which statement is not true regarding therapeutic drug monitoring (TDM)?

Accepted Answer

TDM is performed when the clinical response to a drug can be easily measured.

Answer

TDM is indicated for drugs with a narrow therapeutic index.

Answer

Digoxin is a drug for which TDM is commonly performed.

Answer

TDM is useful when a drug exhibits erratic pharmacokinetics.

Question 7

A drug that binds to a receptor at a site distinct from the active site and alters the affinity of the receptor for the endogenous ligand is a:

Accepted Answer

Allosteric modulator

Answer

Competitive antagonist

Answer

Inverse agonist

Answer

Partial agonist

Question 8

According to the two-state receptor theory, which of the following statements BEST explains the term "agonists"?

Accepted Answer

Strong affinity for the receptor in the active state (Ra)

Answer

Strong affinity for the receptor in the inactive state (Ri)

Answer

Equal affinity for Ra and Ri

Answer

Slightly more affinity for Ra than Ri

Question 9

Which drug does not follow nonlinear dose-dependent saturation kinetics?

Accepted Answer

Paracetamol

Answer

Salicylates

Answer

Phenytoin

Answer

Ethanol

Question 10

Fexofenadine is a metabolic product of which drug?

Accepted Answer

Terfenadine

Answer

Loratadine

Answer

Astemizole

Answer

Cetirizine

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?